List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 4 studies with search of: TNX-355[TREATMENT] AND HIV [CONDITION]
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Unknown † TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1
Condition: HIV Infections
Intervention: Drug: TNX-355
2 Completed Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1
Condition: HIV
Intervention: Drug: Ibalizumab
3 Recruiting Safety Study of Ibalizumab Subcutaneous Injection in Healthy Volunteers
Condition: Prevention of Infection With HIV-1
Intervention: Biological: ibalizumab (biologic/MAb) for SC Injection or placebo
4 Active, not recruiting Investigator-Sponsored Protocol - Continued Use of Ibalizumab
Condition: HIV Infections
Intervention: Drug: ibalizumab

† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services